Clinicians have been interested in the macroscopic and protocol (fig 1) , based on that described by Pin et al 7 using a relatively low output ultrasonic nebuliser (output 0.9 ml/ microscopic appearance of sputum in asthma since the last half of the 19th century when Charcot-Leyden crystals, min, particle size 5.6 m), results in successful sputum induction in 76% of normal and asthmatic subjects who Curschmann's spirals, and their association with sputum eosinophilia was first recognised in patients with asthma. 1 cannot produce sputum spontaneously. Cell counts and biochemical content of induced and spontaneous sputum Forty years ago Morrow Brown suggested that the microscopic examination of sputum might be clinically useful are similar with the exception of fibrinogen which is present in higher concentrations in spontaneous sputum. 11 With by showing that the presence of eosinophils in a crude Leishman stained sputum smear identified patients whose salbutamol premedication and careful monitoring of forced expiratory volume in one second (FEV 1 ) during sputum wheeze was responsive to corticosteroids.
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exacerbations who were overusing inhaled 2 agonists were complicated by a >10% fall in FEV 1 which emphasises the This review describes the development over the last eight years of new and reliable techniques to assess airway need to perform the inductions carefully. 12 We and other investigators have induced sputum in asthma using similar inflammation using sputum differential cell counts and measurement of molecular markers of inflammation in concentrations of hypertonic saline delivered by ultrasonic nebulisers with a higher output and, whilst there might be the sputum fluid phase. We review studies where these measurements have been made in normal and diseased a higher success rate, this is at the expense of increased adverse effects including mild bronchoconstriction.
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subjects and assess their validity, repeatability, and responsiveness. Finally we describe current, and speculate A recent preliminary report has suggested that the cellular and biochemical content of sputum induced by a high on future, applications of sputum measurements of airway inflammation in asthma in both research and clinical setoutput ultrasonic nebuliser changes with sequential inhalatings.
Developments in methodology
Early attempts to provide reliable sputum differential cell counts used smears of spontaneously produced sputum stained with May-Grunwald-Giemsa. 5 Additional staining with toluidine blue was required for accurate metachromatic cell counts. Salivary contamination was minimised by careful selection of sputum plugs and a total cell count was performed after cell dispersion with trypsin. Sputum total and differential cell counts were found to be repeatable between different plugs from the same specimen and between different specimens from the same subject. 5 The sputum eosinophil and metachromatic cell count was considerably higher in subjects with asthma than in those with chronic bronchitis 5 and was responsive to change as indicated by a 4-5 fold increase 32 hours after allergen challenge in subjects with atopic asthma. 6 However, the technique had important limitations. There was difficulty obtaining adequate sputum samples from some subjects, 7 8 cell identification was difficult such that additional staining with chromotrope 2R was sometimes necessary to distinguish eosinophils from neutrophils, 8 the investigation was time consuming, and the measurements were limited to total and differential cell counts. 8 9 Two important innovations have largely overcome these problems. The first is the use of ultrasonically nebulised hypertonic saline to facilitate sputum production. 7 The mechanism by which hypertonic saline induces sputum is incompletely understood but may involve increased outward water flux across the airway epithelium, stimulation tions. 16 In later specimens the cellular changes were consistent with the sputum arising from more distal airways, raising the interesting possibility that it might be possible to measure inflammation selectively in different parts of the tracheobronchial tree. Whether these differences occur with different sputum induction protocols is currently unknown, but until further work is done we recommend that, where possible, the full sputum induction protocol is followed and all the sputum collected is used for cellular and biochemical analysis.
The second important advance has been the use of dithiothreitol (DTT) to improve cell dispersion.
9 17 DTT is a sulphydryl reagent which produces mucolysis by opening disulphide bonds which crosslink glycoprotein fibres and maintain sputum in its gel form. 17 Careful comparisons of sputum selected from saliva and treated with DTT and sputum smears has shown that cell dispersion with DTT is highly effective, making total and differential cell counts easier, quicker, and more reproducible. 9 17 Cell definition is improved in DTT treated sputum, enabling differential cell counts to be performed on Wright's stained cytospins without the need for further stains for eosinophils. If a metachromatic cell count is required additional cytospins still need to be stained with toluidine blue. 9 Cytospins obtained from sputum dispersed with DTT are suitable for immunocytochemical staining of cellular products such as EG-2 reactive protein (a conversion product of eosinophilic cationic protein), granulocytemacrophage colony stimulating factor (GM-CSF), tumour necrosis factor (TNF-), and interleukin (IL)-8. 9 18 The sputum supernatant can be used to measure molecular markers which reflect different aspects of airway inflammation 19 including eosinophil activation (e.g. eosinophilic cationic protein (ECP)), mast cell activation (e.g. tryptase), cytokine production (e.g. IL-5), and microvascular leakage (e.g. albumin and fibrinogen) (table 1). A further exciting possibility is the use of the washed and resuspended cell pellet to study sputum lymphocyte subsets and activation markers by flow cytometry, 20 although with current methods this technique is limited to patients who are able to generate sufficient sputum. CSF, TNF-, IL-8, or most lymphocyte surface markers; it may slightly decrease staining of EG-2 and the human leucocyte antigen HLA-DR.
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Other investigators have developed different techniques for performing sputum differential cell counts and measuring molecular markers of inflammation in the sputum inevitably diluted by saliva and that the extent of this dilution is difficult to quantify accurately. We have recently supernatant.
14 21 The most important difference is whether sputum is selected from the lower respiratory tract or the compared differential cell counts (expressed as a percentage of the non-squamous cells) and fluid phase ECP in selected whole expectorate of sputum plus saliva is processed. Fahy and colleagues have suggested that selection of sputum sputum and in the residual portion 22 and have shown that differential cell counts do not differ but that the quality of might lead to loss of potentially relevant information and have advocated processing of the whole expectorate.
14 21 the cytospins is better in the selected portion, principally because of less salivary squamous cell contamination. More The main disadvantage of this approach is that sputum is importantly, the fluid phase ECP concentration was 5-6 times higher in the selected portion than in the residual so that any effect of salivary dilution is likely to be minimal.
MBP=major basic protein.
So far there is no evidence that relevant information is lost
Normal ranges derived from 10 normal subjects are quoted as median (interquartile range).
by selection.
group.bmj.com on April 6, 2017 -Published by http://thorax.bmj.com/ Downloaded from or cysteinyl-leukotrienes as initially suggested nearly 20 effect to the effects on symptoms and disordered airway function. The addition of sputum measurements of inflammation to an allergen challenge adds a powerful new dimension to these studies. This approach has shown Measurements in disease We have recently used the new method for sputum inthat the inhibitory effect of single doses of salmeterol, formoterol, and beclomethasone on the late response to duction and processing (figs 1 and 2) to measure cell and fluid phase indices of inflammation in normal subjects allergen is not associated with a reduction in allergeninduced eosinophilia. 24 32 Longer term treatment with saland subjects with asthma and non-obstructive chronic bronchitis 19 and have established normal ranges for these meterol also has no effect on the raised sputum eosinophil count compared with placebo in patients with uncontrolled measures (table 2) . We have confirmed previous findings using sputum smears on the validity of sputum inasthma despite improving symptoms and airflow obstruction, whereas an increased dose of inhaled steroid flammatory cell counts by showing that eosinophil and metachromatic cell counts tend to be higher in subjects causes a parallel improvement in clinical measures and measures of airway inflammation. 25 Similar acute and with asthma than in normal and bronchitic subjects, and have shown for the first time that sputum from subjects longer term studies would be possible with other drugs with putative anti-inflammatory effects such as theophylline with asthma contains a slight excess of neutrophils. Sputum inflammatory cell counts are highly repeatable. The within and antileukotrienes. Alternatively, sputum could be used to assess a possible pro-inflammatory effect of chronic subject repeatability of sputum eosinophil counts in subjects with asthma is such that 95% of repeated measures treatment with 2 agonists. The use of induced sputum to assess airway inlie within a twofold range of the original measurement.
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Sputum fluid phase ECP, tryptase, fibrinogen, and albumin flammation in a clinical setting has already led to important increases in our understanding of the relationship between concentrations were higher in sputum from subjects with asthma than from normal subjects and were repeatable. 18 airway inflammation and disordered airway function. Studies have generally not shown a correlation between eos-ECP and tryptase concentrations correlated positively with the sputum eosinophil and metachromatic differential cell inophilic airway inflammation and airway responsiveness to direct 7 20 or indirect 33 challenge between subjects with count, in keeping with their suspected cellular origin (table  1) .
asthma, suggesting that the relationship between these features of asthma is more complex than was once thought. Sputum cell and fluid phase indices of inflammation were also responsive to change as indicated by an increase However, there is a correlation between the change in airway responsiveness and the change in sputum eosinophil in sputum eosinophils, metachromatic cells, tryptase, and ECP after allergen challenge 21 24 and a decrease after treatcount after allergen challenge 6 which suggests that within subjects these features are related. The absence of a rement with oral and inhaled corticosteroids.
23 25 The difference between normal and asthmatic subjects and the effect lationship between eosinophilic airway inflammation and airway hyperresponsiveness between subjects is most strikof intervention with allergen and corticosteroids are similar in direction but more marked than changes seen in studies ingly illustrated by the identification of a group of patients with a corticosteroid responsive chronic cough and sputum using bronchoalveolar lavage, 26-28 which suggests that sputum yields samples that are representative of events in the evidence of a florid eosinophilic bronchitis but normal spirometric values, airway responsiveness to direct and lower airway. This assumption is supported by recent studies showing a reasonably close correlation between indirect challenge, and peak expiratory flow variability. 34 35 Furthermore, a substantial proportion of patients with differential eosinophil counts in sputum and bronchial washings in normal and asthmatic subjects. 29 30 Conuncontrolled asthma and considerable airway hyperresponsiveness and variable airflow obstruction have no centrations of ECP and most other molecular markers of inflammation are considerably higher in sputum than in eosinophilic inflammation. 36 37 Since the available evidence suggests that corticosteroids are considerably more effective bronchoalveolar lavage fluid which suggests that sputum is richer in airway secretions than samples obtained by when there is evidence of eosinophilic inflammation, 2 these findings raise important questions about the universal use bronchoscopy.
of increased doses of inhaled corticosteroids or oral corticosteroids in uncontrolled asthma and suggest that knowledge of the nature of the underlying airway inflammation could Initial research and clinical applications The new reliable methods for obtaining and processing be used to target additional treatment in uncontrolled asthma. sputum in asthma raise exciting clinical and research possibilities since measurement of cellular and molecular inThe use of sputum to assess airway inflammation in conditions other than asthma has not been extensively dices of inflammation in sputum represents the only direct and practical way to assess airway inflammation serially in explored. Non-obstructive chronic bronchitis is associated with a mild sputum neutrophilia but normal eosinophil large numbers of patients. One obvious application is to use sputum inflammatory indices to increase our undercounts and sputum ECP concentrations, 19 whereas chronic obstructive pulmonary disease (COPD) is associated with standing of complex relationships between inflammatory cell and mediator and cytokine mechanisms in asthma.
a marked sputum neutrophilia together with increased sputum concentrations of TNF-and IL-8. 38 Whether The sputum fluid phase seems to be suitable to measure ECP, some cytokines, and histamine, and may be suitable demonstration of a sputum eosinophilia by the new reliable methods in patients with what appears to be COPD idenfor measurements of other mediators such as prostanoids group.bmj.com on April 6, 2017 -Published by http://thorax.bmj.com/ Downloaded from to be determined, although studies using earlier techniques 14 
